Offer - Urjas Oil for just ₹ 1
Oncotrex 2.5 Mg Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Oncotrex 2.5 Mg Tablet safe for pregnant women?
Pregnant women may get severe side effects after taking Oncotrex. If you are pregnant, do not take Oncotrex without a doctor's advice.
Is the use of Oncotrex 2.5 Mg Tablet safe during breastfeeding?
Oncotrex may cause serious side effects in breastfeeding women, so do not take this drug without doctor's advice.
What is the effect of Oncotrex 2.5 Mg Tablet on the Kidneys?
Oncotrex may cause harmful effects on kidney. if you feel its having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Oncotrex 2.5 Mg Tablet on the Liver?
You may experience side effects on your liver after taking Oncotrex. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Oncotrex 2.5 Mg Tablet on the Heart?
Side effects of Oncotrex rarely affect the heart.
If you are suffering from any of the following diseases, you should not take Oncotrex 2.5 Mg Tablet unless your doctor advises you to do so -
Is this Oncotrex 2.5 Mg Tablet habit forming or addictive?
Oncotrex 2.5 Mg Tablet does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can operate a vehicle or heavy machinery after taking Oncotrex 2.5 Mg Tablet since it does not cause drowsiness.
Is it safe?
Yes, Oncotrex 2.5 Mg Tablet is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
There is no benefit of taking Oncotrex 2.5 Mg Tablet for mental disorders.
Interaction between Food and Oncotrex 2.5 Mg Tablet
Due to a lack of research, nothing can be said about the consequences of taking Oncotrex 2.5 Mg Tablet together with food.
Interaction between Alcohol and Oncotrex 2.5 Mg Tablet
Taking Oncotrex 2.5 Mg Tablet and alcohol together may cause some problems. If you notice any of these side effects, it is best to go to your doctor.
Oncotrex contains methotrexate (a chemotherapy) which is used in the treatment of various types of cancers. Nonetheless, it has been associated with an increased risk for melanoma, non-Hodgkin's lymphoma, and lung cancer.
No, Oncotrex is a prescription drug so do not take it without consulting a doctor. It can be harmful for the patient to take this medicine without a doctor's recommendation because it can cause unpleasant side effects. Hence, the patient should seek doctors advice before taking this medication by himself or herself.
No, Oncotrex does not cause weight changes (weight gain or loss). It has not been reported by the patients who are taking this drug. However, if you are experiencing any unusual weight changes then it might be due to some other medical condition and you are advised to discuss it with your doctor.
Oncotrex is a brand name of methotrexate and it comes in the form of tablet and injection. It is a chemotherapy drug that belongs to the class of drug known as antimetabolites and it also has immunosuppressant properties. It is a prescription drug which is used for the treatment of various types of cancers such as breast cancer, bone cancer, head, and neck cancer. It is also used in the treatment of autoimmune and inflammatory diseases such as psoriasis, rheumatoid arthritis, and Crohn's disease.
Yes, Oncotrex can be taken with clindamycin. No harmful drug interaction has been reported between them. It is safe to take Oncotrex along with clindamycin.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Methotrexate
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 862-863
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 832-834